Does Pegasys Cause Depression or Mood Changes?
Yes, Pegasys (peginterferon alfa-2a), used for hepatitis B and C, lists depression and mood changes as known side effects. Clinical trials and post-marketing reports show these occur in 20-30% of patients, sometimes severely enough to require discontinuation.[1][2]
How Common Are These Effects?
In pivotal trials for hepatitis C:
- Depression affected 22% of patients on Pegasys plus ribavirin, versus 10% on ribavirin alone.
- Severe depression (suicidal ideation or attempts) hit 2-4%.[3]
Mood swings, irritability, and anxiety also appear frequently, often starting within weeks of treatment.[1]
Why Does It Happen?
Interferons like Pegasys trigger immune responses that alter brain serotonin levels and inflammation pathways, mimicking flu-like symptoms that escalate to neuropsychiatric issues. Risk factors include prior mental health history, female sex, and higher doses.[4]
What Do Patients Report?
Real-world data from FDA adverse event reports (FAERS) logs over 5,000 cases of depression and 2,000+ of mood disorders linked to Pegasys since approval. Suicidal thoughts appear in ~1% of reports, with onset typically 1-3 months in.[2][5] Forums like Drugs.com note user experiences of "crushing sadness" or rage, often resolving post-treatment.
How Is It Managed?
Screen for depression before starting; monitor with scales like PHQ-9. Antidepressants (e.g., SSRIs) help 60-70% of cases without reducing Pegasys efficacy. Dose reduction or stopping resolves symptoms in most.[1][6] Ribavirin combo worsens risk.
Who Is at Higher Risk?
- History of depression or suicide attempts: Avoid or use extreme caution.
- Age >50 or thyroid issues: 1.5-2x higher odds.
- Alcohol use or HCV genotype 1: Elevates incidence.[3][4]
Compared to Similar Treatments
Pegasys has higher neuropsychiatric rates than direct-acting antivirals (DAAs) like sofosbuvir (depression <5%). Older interferons (Intron) show similar 20-25% rates, but Pegasys's longer half-life may prolong effects.[7]
[1]: Pegasys Prescribing Information (FDA)
[2]: FAERS Database (FDA)
[3]: NEJM Trial (2002)
[4]: Hepatology Review (2010)
[5]: Drugs.com Side Effects
[6]: AASLD Guidelines
[7]: JAMA Comparison (2018)